P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.2004-0137PMID 15483100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease

  2003cited by this paper
• The platelet in diabetes: focus on prevention of ischemic events.

  2003cited by this paper
• Blockade of the Platelet P2Y12 Receptor by AR-C69931MX Sustains Coronary Artery Recanalization and Improves the Myocardial Tissue Perfusion in a Canine Thrombosis Model

  2003cited by this paper
• Association of CIB with GPIIb/IIIa during outside-in signaling is required for platelet spreading on fibrinogen.

  2003cited by this paper
• Thrombospondin‐1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor

  2003cited by this paper
• Purinergic P2Y12 receptor blockade inhibits shear-induced platelet phosphatidylinositol 3-kinase activation.

  2003cited by this paper
• Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity.

  2003cited by this paper
• Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.

  2002cited by this paper
• Aspirin with bypass surgery--from taboo to new standard of care.

  2002cited by this paper
• Platelet Aggregation and Activation under Complex Patterns of Shear Stress

  2002cited by this paper
• Lack of α2-Antiplasmin Enhances ADP Induced Platelet Micro-Aggregation through the Presence of Excess Active Plasmin in Mice

  2002cited by this paper
• Thrombostatin, a bradykinin metabolite, reduces platelet activation in a model of arterial wall injury.

  2002cited by this paper
• Effects of P2Y 1 and P2Y 12 receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets

  2002cited by this paper
• Distinct roles of GPVI and integrin α2β1 in platelet shape change and aggregation induced by different collagens

  2002cited by this paper
• 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.

  2002cited by this paper
• Involvement of Glycoprotein VI in Platelet Thrombus Formation on Both Collagen and von Willebrand Factor Surfaces Under Flow Conditions

  2002cited by this paper
• Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation.

  2002cited by this paper
• Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.

  2002cited by this paper
• 2‐Chloro N6‐methyl‐(N)‐methanocarba‐2′‐deoxyadenosine‐3′,5′‐bisphosphate is a selective high affinity P2Y1 receptor antagonist

  2002cited by this paper
• Sex difference in platelet aggregation detected by new aggregometry using light scattering.

  2001cited by this paper
• Platelet dysfunction in type 2 diabetes.

  2001cited by this paper
• Differential Involvement of the P2Y1 and P2YT Receptors in the Morphological Changes of Platelet Aggregation

  2001cited by this paper
• Enhanced platelet aggregation in the coronary circulation after coronary spasm.

  2001cited by this paper
• Rapid Change of Platelet Aggregability in Acute Hyperglycemia

  2000cited by this paper
• Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex.

  2000cited by this paper
• Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets.

  2000cited by this paper
• Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome

  2000cited by this paper
• Platelet activation by ADP: the role of ADP antagonists.

  2000cited by this paper
• Molecular basis of androgen receptor diseases

  2000cited by this paper
• Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates

  1999cited by this paper
• Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice

  1999cited by this paper
• Insulin Stimulates Nitric Oxide Synthesis in Human Platelets and, Through Nitric Oxide, Increases Platelet Concentrations of Both Guanosine-3′, 5′-Cyclic Monophosphate and Adenosine-3′, 5′-Cyclic Monophosphate

  1997cited by this paper
• Mechanisms Initiating Platelet Thrombus Formation

  1997cited by this paper
• Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated aurintricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery.

  1997cited by this paper
• Aspirin Therapy in Diabetes

  1997cited by this paper
• GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster

  1997cited by this paper
• The Antithrombotic Effect of Aurin Tricarboxylic Acid in the Guinea Pig Is not Solely due to Its Interaction with the von Willebrand Factor-GPIb Axis

  1996cited by this paper
• Development of Large Platelet Aggregates from Small Aggregates as Determined by Laser-light Scattering: Effects of Aggregant Concentration and Antiplatelet Medication

  1996cited by this paper
• Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation.

  1996cited by this paper
• Antiplatelet therapy.

  1996cited by this paper
• Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo

  1994cited by this paper
• Detection of platelet aggregates with a particle counting method using light scattering.

  1994cited by this paper
• Increased intracellular calcium mobilization in platelets from patients with Type 2 (non-insulin-dependent) diabetes mellitus

  1991cited by this paper
• Monoclonal antibodies bound to subunits of the integrin GPIIb-IIIa are internalized and interfere with filopodia formation and platelet aggregation.

  1990cited by this paper
• Aggregin: a platelet ADP receptor that mediates activation

  1990cited by this paper
• Diabetic Myocardial Infarction: Interaction of Diabetes With Other Preinfarction Risk Factors

  1989cited by this paper
• Plasma fibronectin and platelet aggregation in diabetes mellitus.

  1986cited by this paper
• Light scattering vs. microscopy for measuring average cell size and shape.

  1979cited by this paper
• The study of platelet aggregation in whole blood [proceedings].

  1979cited by this paper
• Effects of the Numbers and Sizes of Platelet Aggregates on the Optical Density of Plasma

  1967cited by this paper

• Platelet indices as predictors of poor glucoregulation in type 2 diabetes mellitus adults at Bishoftu General Hospital, Ethiopia

  2024cites this paper
• Inverse relationship between platelet Akt activity and hippocampal atrophy: A pilot case-control study in patients with diabetes mellitus

  2024cites this paper
• Cold temperature induces a TRPM8-independent calcium release from the endoplasmic reticulum in human platelets

  2024cites this paper
• The Signaling Pathway of the ADP Receptor P2Y12 in the Immune System: Recent Discoveries and New Challenges

  2023cites this paper
• G protein-coupled P2Y12 receptor is involved in the progression of neuropathic pain.

  2023cites this paper
• Cold temperature induces a TRPM8-independent calcium release from the endoplasmic reticulum in human platelets

  2023cites this paper
• P2Y12 receptor involved in the development of chronic nociceptive pain as a sensory information mediator.

  2023cites this paper
• Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia

  2022cites this paper
• Platelets in Non-alcoholic Fatty Liver Disease

  2022cites this paper
• Relationship between the Responsiveness of Amyloid β Protein to Platelet Activation by TRAP Stimulation and Brain Atrophy in Patients with Diabetes Mellitus

  2022cites this paper
• Amyloid β protein negatively regulates human platelet activation induced by thrombin receptor-activating protein.

  2021cites this paper
• “MEAN PLATELET VOLUME CORRELATED TO GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS”

  2021cites this paper
• Incidence and characteristics of spontaneous platelet macro-aggregation in acute ischemic stroke

  2020cites this paper
• Influence of Cardiometabolic Risk Factors on Platelet Function

  2020cites this paper
• The release of phosphorylated-HSP27 from activated platelets of obstructive sleep apnea syndrome (OSAS) patients.

  2019cites this paper
• Collagen-Induced Platelet Aggregates, Diabetes, and Aspirin Therapy Predict Clinical Outcomes in Acute Ischemic Stroke.

  2019cites this paper
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets

  2018cites this paper
• Thromboinflammatory Functions of Platelets in Ischemia–Reperfusion Injury and Its Dysregulation in Diabetes

  2018cites this paper
• Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release.

  2018cites this paper
• Spontaneous Micro-Aggregation of Platelets Predicts Clinical Outcome in Acute Ischemic Stroke.

  2018cites this paper
• Effects of endurance training on hsa-miR-223, P2RY12 receptor expression and platelet function in type 2 diabetic patients

  2018cites this paper
• Platelets and Diabetes

  2017cites this paper
• Diabetespatienten mit kardiovaskulärer Erkrankung

  2016cites this paper
• Thrombin Receptor-Activating Protein (TRAP)-Activated Akt Is Involved in the Release of Phosphorylated-HSP27 (HSPB1) from Platelets in DM Patients

  2016cites this paper
• Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus

  2016cites this paper
• Vitamin D3 prevents the increase in ectonucleotidase activities and ameliorates lipid profile in type 1 diabetic rats

  2015cites this paper
• Release of Phosphorylated HSP27 (HSPB1) from Platelets Is Accompanied with the Acceleration of Aggregation in Diabetic Patients

  2015cites this paper
• Mechanisms of hypoglycaemia related sudden cardiac death in type 2 diabetes mellitus

  2015cites this paper
• Single nucleotide polymorphism of CYP3A5*3 contributes to clopidogrel resistance in coronary artery disease patients among Tamilian population

  2014cites this paper
• Residual platelet reactivity in atherosclerosis and its impact on patient outcomes

  2014cites this paper
• [Blood viscosity in patients with ischemic heart disease].

  2014cites this paper
• [Value of Fatty acids in formation of thrombotic status in patients with ischemic heart disease].

  2014cites this paper
• Chapter 35 – Diabetes Mellitus

  2013cites this paper
• Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction

  2013cites this paper
• Modulation of P2 receptors on pancreatic β-cells by agonists and antagonists: a molecular target for type 2 diabetes treatment.

  2013cites this paper
• Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin

  2013cites this paper
• Platelet Function Profiles in Patients with Diabetes Mellitus

  2013cites this paper
• Impact of diabetes on platelet activation in different manifestations of atherosclerosis.

  2013cites this paper
• Clopidogrel "resistance": pre- vs post-receptor determinants.

  2013cites this paper
• Significant correlation between the acceleration of platelet aggregation and phosphorylation of HSP27 at Ser-78 in diabetic patients.

  2012cites this paper
• Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease.

  2012cites this paper
• Promotion of Blood Fluidity Using Electroacupuncture Stimulation

  2012cites this paper
• Changes of blood fluidity in the early hepatopathy in rats.

  2012cites this paper
• Efeitos do resveratrol, do suco de uva e do vinho tinto nos biomarcadores de estresse oxidativo e na atividade de ectoenzimas em ratos diabéticos

  2012cites this paper
• Promotion of blood fluidity by inhibition of platelet adhesion using electroacupuncture stimulation.

  2011cites this paper
• Influence of Chinese Herbal Medicine on Reactive Oxygen and Blood Fluidity in Rats

  2011cites this paper
• Blood Fluidity Enhancement by Electrical Acupuncture Stimulation is Related to an Adrenergic Mechanism

  2011cites this paper
• Review article: Platelet abnormalities in diabetes mellitus

  2010influential citation
• Advances in antiplatelet therapy for stroke prevention: the new P2Y12 antagonists.

  2010cites this paper
• Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis.

  2010cites this paper
• Activated platelet profile and albuminuria Correlation between albuminuria and spontaneous platelet micro-aggregate formation in type 2 diabetic patients Running title: Activated platelet profile and albuminuria

  2009cites this paper
• Real-time Evaluation of Hemocompatible Materials by Human Platelets as an Alternative to Animal Experimentation

  2009cites this paper
• Correlation Between Albuminuria and Spontaneous Platelet Microaggregate Formation in Type 2 Diabetic Patients

  2009cites this paper
• Validity of Particle-Counting Method Using Laser-Light Scattering for Detecting Platelet Aggregation in Diabetic Patients

  2009cites this paper
• Состояние системы гемостаза и функции эндотелия при различных подтипах ишемического инсульта в остром и восстановительном периодах

  2009cites this paper
• Raloxifene enhances spontaneous microaggregation of platelets through upregulation of p44/p42 MAP kinase: a case report

  2009cites this paper
• Collagen-induced p38 MAP kinase activation is a biomarker of platelet hyper-aggregation in patients with diabetes mellitus.

  2009cites this paper
• Utility of aspirin therapy in patients with the cardiometabolic syndrome and diabetes.

  2009cites this paper
• Efecto del cizallamiento y del difosfato de adenosina sobre la activacion plaquetaria y la formacion de microagregados en controles sanos. Valoracion mediante citometria de flujo

  2009cites this paper
• Raloxifene-induced acceleration of platelet aggregation.

  2008cites this paper
• Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome.

  2008cites this paper
• Review: Aspirin and Diabetes Mellitus: revisiting an old player

  2008cites this paper
• Platelet Activation and Red Blood Cell Phosphatidylserine Exposure Evaluated by Flow Cytometry in Patients with Behçet’s Disease: Are They Related to Thrombotic Events?

  2008cites this paper
• Enhanced NTPDase and 5′-nucleotidase activities in diabetes mellitus and iron-overload model

  2007cites this paper
• Individual variation in in vitro efficacy of antiplatelet medication - aspirin and clopidogrel

  2007cites this paper
• Thienopyridines in cardiovascular disease: Focus on Clopidogrel resistance

  2007cites this paper
• Role of purinergic receptors in platelet-nanoparticle interactions

  2007cites this paper
• NTPDase and 5'‐nucleotidase activities in physiological and disease conditions: New perspectives for human health

  2007cites this paper
• Platelet resistance to the anti-aggregating agents in the insulin resistant states.

  2006cites this paper
• Thrombozytenhemmung und -aktivierung

  2005cites this paper
• Aspirin response and failure in diabetic patients with cardiovascular disease.

  2005cites this paper
• [Platelet inhibition and activation. Mechanisms and clinical implications].

  2005cites this paper
• Management of patients with type 2 diabetes after acute coronary syndromes

  2005cites this paper
• Compression force sensing regulates integrin alpha ( IIb ) beta ( 3 ) adhesive function on diabetic platelets

  year unknowncites this paper
• World Journal of Diabetes

  year unknowncites this paper